Cancer, ISSN 0008-543X, 06/2009, Volume 115, Issue 11, pp. 2523 - 2530
BACKGROUND: Actinic keratoses (AKs) are established as direct precursors of squamous cell carcinoma (SCC), but there is significant controversy regarding the...
Squamous cell carcinoma | Basal cell carcinoma | Actinic keratoses | Nonmelanoma skin cancer | Epidemiology | actinic keratoses | RELIABILITY | PREVALENCE | SOLAR KERATOSES | epidemiology | NONMELANOMA SKIN-CANCER | ONCOLOGY | QUEENSLAND | FREQUENCY | nonmelanoma skin cancer | SQUAMOUS-CELL CARCINOMA | basal cell carcinoma | VATTC TRIAL | ASSOCIATION | squamous cell carcinoma | Carcinoma, Squamous Cell - epidemiology | Humans | Middle Aged | Male | Risk | Carcinoma, Basal Cell - epidemiology | Skin Neoplasms - epidemiology | Disease Progression | Time Factors | Aged, 80 and over | Adult | Female | Precancerous Conditions - pathology | Aged | Keratosis, Actinic - pathology | Actinic keratosis | Complications and side effects | Patient outcomes | Development and progression | Research | Risk factors
Squamous cell carcinoma | Basal cell carcinoma | Actinic keratoses | Nonmelanoma skin cancer | Epidemiology | actinic keratoses | RELIABILITY | PREVALENCE | SOLAR KERATOSES | epidemiology | NONMELANOMA SKIN-CANCER | ONCOLOGY | QUEENSLAND | FREQUENCY | nonmelanoma skin cancer | SQUAMOUS-CELL CARCINOMA | basal cell carcinoma | VATTC TRIAL | ASSOCIATION | squamous cell carcinoma | Carcinoma, Squamous Cell - epidemiology | Humans | Middle Aged | Male | Risk | Carcinoma, Basal Cell - epidemiology | Skin Neoplasms - epidemiology | Disease Progression | Time Factors | Aged, 80 and over | Adult | Female | Precancerous Conditions - pathology | Aged | Keratosis, Actinic - pathology | Actinic keratosis | Complications and side effects | Patient outcomes | Development and progression | Research | Risk factors
Journal Article
2.
Full Text
Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource data
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 03/2014, Volume 28, Issue 3, pp. 309 - 313
Background In Europe, only few and inconsistent data on the prevalence and treatment of actinic keratoses (AK) are available. Objectives To determine the...
POPULATION | COST | NONMELANOMA SKIN-CANCER | COHORT | CARE | SOLAR KERATOSES | DERMATOLOGY | Young Adult | Keratosis, Actinic - epidemiology | Prevalence | Humans | Middle Aged | Risk Factors | Adolescent | Adult | Female | Male | Aged | Germany - epidemiology | Sunburn | Melanoma | Prevalence studies (Epidemiology) | Keratosis
POPULATION | COST | NONMELANOMA SKIN-CANCER | COHORT | CARE | SOLAR KERATOSES | DERMATOLOGY | Young Adult | Keratosis, Actinic - epidemiology | Prevalence | Humans | Middle Aged | Risk Factors | Adolescent | Adult | Female | Male | Aged | Germany - epidemiology | Sunburn | Melanoma | Prevalence studies (Epidemiology) | Keratosis
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2007, Volume 156, Issue 2, pp. 222 - 230
Summary These guidelines stemmed from a consensus meeting held by the British Photobiology Group (BPG) in 1999. Following this meeting one of the authors...
treatment | guidelines | actinic keratosis | Actinic keratosis | Treatment | Guidelines | RANDOMIZED-CONTROLLED-TRIAL | TRANSPLANT RECIPIENTS | SOLAR KERATOSES | DERMATOLOGY | TOPICAL PHOTODYNAMIC THERAPY | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | 5-PERCENT IMIQUIMOD CREAM | TRICHLOROACETIC-ACID | 2.5-PERCENT HYALURONAN GEL | SKIN-CANCER | Skin Neoplasms - therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Photochemotherapy - methods | Humans | Keratosis - therapy | Risk Factors | Antineoplastic Agents - therapeutic use | Skin Neoplasms - etiology | Administration, Cutaneous | Keratosis - diagnosis | Surgical Procedures, Operative - methods | Ultraviolet Rays - adverse effects
treatment | guidelines | actinic keratosis | Actinic keratosis | Treatment | Guidelines | RANDOMIZED-CONTROLLED-TRIAL | TRANSPLANT RECIPIENTS | SOLAR KERATOSES | DERMATOLOGY | TOPICAL PHOTODYNAMIC THERAPY | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | 5-PERCENT IMIQUIMOD CREAM | TRICHLOROACETIC-ACID | 2.5-PERCENT HYALURONAN GEL | SKIN-CANCER | Skin Neoplasms - therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Photochemotherapy - methods | Humans | Keratosis - therapy | Risk Factors | Antineoplastic Agents - therapeutic use | Skin Neoplasms - etiology | Administration, Cutaneous | Keratosis - diagnosis | Surgical Procedures, Operative - methods | Ultraviolet Rays - adverse effects
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2007, Volume 157, Issue s2, pp. 34 - 40
Summary Background Actinic keratoses (AK) frequently occur on sun-exposed skin and are considered as in situ squamous cell carcinoma. To date, no treatment...
5-fluorouracil | actinic keratoses | comparative study | cryosurgery | imiquimod | field cancerisation | 5‐fluorouracil | Field cancerisation | 5-Fluorouracil | Cryosurgery | Actinic keratoses | Imiquimod | Comparative study | EFFICACY | PERSPECTIVE | SOLAR KERATOSIS | FLUOROURACIL | FORMULATION | DERMATOLOGY | TRIAL | THERAPY | CREAM | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | Neoplasms, Radiation-Induced - surgery | Skin Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Keratosis - drug therapy | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Immunocompetence | Skin Neoplasms - surgery | Esthetics | Treatment Outcome | Neoplasms, Radiation-Induced - drug therapy | Ultraviolet Rays - adverse effects | Carcinoma, Squamous Cell - drug therapy | Aged | Cryosurgery - adverse effects | Aminoquinolines - therapeutic use | Aminoquinolines - adverse effects | Medical research | Algorithms | Surgery | Patient outcomes | Medicine, Experimental | Comparative analysis | Fluorouracil | Keratosis
5-fluorouracil | actinic keratoses | comparative study | cryosurgery | imiquimod | field cancerisation | 5‐fluorouracil | Field cancerisation | 5-Fluorouracil | Cryosurgery | Actinic keratoses | Imiquimod | Comparative study | EFFICACY | PERSPECTIVE | SOLAR KERATOSIS | FLUOROURACIL | FORMULATION | DERMATOLOGY | TRIAL | THERAPY | CREAM | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | Neoplasms, Radiation-Induced - surgery | Skin Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Keratosis - drug therapy | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Immunocompetence | Skin Neoplasms - surgery | Esthetics | Treatment Outcome | Neoplasms, Radiation-Induced - drug therapy | Ultraviolet Rays - adverse effects | Carcinoma, Squamous Cell - drug therapy | Aged | Cryosurgery - adverse effects | Aminoquinolines - therapeutic use | Aminoquinolines - adverse effects | Medical research | Algorithms | Surgery | Patient outcomes | Medicine, Experimental | Comparative analysis | Fluorouracil | Keratosis
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 05/2007, Volume 156, Issue 5, pp. 793 - 801
Summary Methyl aminolaevulinate–photodynamic therapy (MAL‐PDT) has advanced the management of nonmelanoma skin cancer (NMSC), providing a treatment option for...
actinic keratoses | basal cell carcinoma | Bowen's disease | photodynamic therapy | review | methyl aminolaevulinate | Methyl aminolaevulinate | Basal cell carcinoma | Photodynamic therapy | Review | Actinic keratoses | SURGERY | TOPICAL APPLICATION | CRYOTHERAPY | RANDOMIZED MULTICENTER | SOLAR KERATOSES | DERMATOLOGY | BASAL-CELL CARCINOMA | 5-AMINOLEVULINIC ACID | Skin Neoplasms - drug therapy | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Bowen's Disease - drug therapy | Humans | Aminolevulinic Acid - analogs & derivatives | Carcinoma, Basal Cell - drug therapy | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Keratosis - drug therapy | Clinical trials | Care and treatment | Melanoma | Cancer | Skin cancer | Keratosis
actinic keratoses | basal cell carcinoma | Bowen's disease | photodynamic therapy | review | methyl aminolaevulinate | Methyl aminolaevulinate | Basal cell carcinoma | Photodynamic therapy | Review | Actinic keratoses | SURGERY | TOPICAL APPLICATION | CRYOTHERAPY | RANDOMIZED MULTICENTER | SOLAR KERATOSES | DERMATOLOGY | BASAL-CELL CARCINOMA | 5-AMINOLEVULINIC ACID | Skin Neoplasms - drug therapy | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Bowen's Disease - drug therapy | Humans | Aminolevulinic Acid - analogs & derivatives | Carcinoma, Basal Cell - drug therapy | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Keratosis - drug therapy | Clinical trials | Care and treatment | Melanoma | Cancer | Skin cancer | Keratosis
Journal Article
Dermatologic Surgery, ISSN 1076-0512, 09/2017, Volume 43, Issue 9, pp. 1170 - 1175
BACKGROUNDActinic keratoses (AKs) are skin lesions resulting from sun exposure and carry a risk of developing into squamous cell carcinoma. Current therapies...
TRIAL | SURGERY | TOPICAL FLUOROURACIL | CREAM | MALIGNANT-TRANSFORMATION | CRYOTHERAPY | SQUAMOUS-CELL CARCINOMA | SOLAR KERATOSES | IMIQUIMOD | DERMATOLOGY | Esthetics | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Dermatologic Agents - therapeutic use | Aminolevulinic Acid - adverse effects | Dermatologic Agents - adverse effects | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Keratosis, Actinic - drug therapy | Aged, 80 and over | Female | Aged | Drug Therapy, Combination | Actinic keratosis | Treatment outcome | Care and treatment | Usage | Patient outcomes | Analysis | Dosage and administration | Research | Comparative analysis | Photochemotherapy | Fluorouracil | Cancer | Index Medicus
TRIAL | SURGERY | TOPICAL FLUOROURACIL | CREAM | MALIGNANT-TRANSFORMATION | CRYOTHERAPY | SQUAMOUS-CELL CARCINOMA | SOLAR KERATOSES | IMIQUIMOD | DERMATOLOGY | Esthetics | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Dermatologic Agents - therapeutic use | Aminolevulinic Acid - adverse effects | Dermatologic Agents - adverse effects | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Keratosis, Actinic - drug therapy | Aged, 80 and over | Female | Aged | Drug Therapy, Combination | Actinic keratosis | Treatment outcome | Care and treatment | Usage | Patient outcomes | Analysis | Dosage and administration | Research | Comparative analysis | Photochemotherapy | Fluorouracil | Cancer | Index Medicus
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 05/2007, Volume 156, Issue s3, pp. 13 - 17
Summary Background Actinic keratoses (AKs) are among the most common cutaneous malignancies and have previously been classified as in situ squamous cell...
reflectance confocal microscopy | actinic keratoses | non-invasive imaging | non-melanoma skin cancer | field cancerisation | non‐melanoma skin cancer | non‐invasive imaging | HUMAN SKIN | MOHS MICROGRAPHIC SURGERY | SCANNING LASER MICROSCOPY | SOLAR KERATOSES | DERMATOLOGY | CONFOCAL REFLECTANCE MICROSCOPY | BASAL-CELL CARCINOMA | IN-VIVO | CONTRAST | REAL-TIME | Skin Neoplasms - pathology | Sunlight - adverse effects | Humans | Precancerous Conditions - pathology | Biopsy, Needle | Keratosis - pathology | Microscopy, Confocal - methods | Disease Progression | Skin - pathology | Development and progression | Diagnosis | Keratosis
reflectance confocal microscopy | actinic keratoses | non-invasive imaging | non-melanoma skin cancer | field cancerisation | non‐melanoma skin cancer | non‐invasive imaging | HUMAN SKIN | MOHS MICROGRAPHIC SURGERY | SCANNING LASER MICROSCOPY | SOLAR KERATOSES | DERMATOLOGY | CONFOCAL REFLECTANCE MICROSCOPY | BASAL-CELL CARCINOMA | IN-VIVO | CONTRAST | REAL-TIME | Skin Neoplasms - pathology | Sunlight - adverse effects | Humans | Precancerous Conditions - pathology | Biopsy, Needle | Keratosis - pathology | Microscopy, Confocal - methods | Disease Progression | Skin - pathology | Development and progression | Diagnosis | Keratosis
Journal Article
CLINICAL INTERVENTIONS IN AGING, ISSN 1176-9092, 2013, Volume 8, pp. 29 - 35
The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and...
photodynamic therapy | FLUOROURACIL | actinic keratosis | SOLAR KERATOSES | GERIATRICS & GERONTOLOGY | CONTROLLED-TRIALS | topical chemotherapy | 5-FLUOROURACIL | IMIQUIMOD 5-PERCENT CREAM | NONMELANOMA SKIN-CANCER | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | field therapy | INGENOL MEBUTATE GEL | Precancerous Conditions - therapy | Keratosis, Actinic - therapy | Photochemotherapy - methods | Humans | Aging | Keratosis, Actinic - prevention & control | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Cryotherapy - methods | Precancerous Conditions - prevention & control | Sunscreening Agents - administration & dosage | Actinic keratosis | Photodynamic therapy | Field therapy | Topical chemotherapy | Prevention | Care and treatment | Squamous cell carcinoma | Skin | Research | Medicine, Preventive | Health aspects | Preventive health services | Disease prevention | Chemotherapy | Sunburn & sun tanning | Skin cancer | Review
photodynamic therapy | FLUOROURACIL | actinic keratosis | SOLAR KERATOSES | GERIATRICS & GERONTOLOGY | CONTROLLED-TRIALS | topical chemotherapy | 5-FLUOROURACIL | IMIQUIMOD 5-PERCENT CREAM | NONMELANOMA SKIN-CANCER | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | field therapy | INGENOL MEBUTATE GEL | Precancerous Conditions - therapy | Keratosis, Actinic - therapy | Photochemotherapy - methods | Humans | Aging | Keratosis, Actinic - prevention & control | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Cryotherapy - methods | Precancerous Conditions - prevention & control | Sunscreening Agents - administration & dosage | Actinic keratosis | Photodynamic therapy | Field therapy | Topical chemotherapy | Prevention | Care and treatment | Squamous cell carcinoma | Skin | Research | Medicine, Preventive | Health aspects | Preventive health services | Disease prevention | Chemotherapy | Sunburn & sun tanning | Skin cancer | Review
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 05/2018, Volume 32, Issue 5, pp. 745 - 751
Background Common histological classification schemes of actinic keratoses (AK) do not evaluate growth patterns at basal epidermal aspects of AK. Until now,...
SQUAMOUS-CELL CARCINOMA | SOLAR KERATOSIS | PERSPECTIVE | TREATMENT ALGORITHM | PROGRESSION | DERMATOLOGY | Epidermis - pathology | Facial Dermatoses - classification | Humans | Middle Aged | Male | Facial Dermatoses - pathology | Epidermis - growth & development | Keratinocytes - pathology | Keratosis, Actinic - classification | Aged, 80 and over | Female | Aged | Retrospective Studies | Keratosis, Actinic - pathology | Medicine, Experimental | Medical research | Analysis | Keratosis
SQUAMOUS-CELL CARCINOMA | SOLAR KERATOSIS | PERSPECTIVE | TREATMENT ALGORITHM | PROGRESSION | DERMATOLOGY | Epidermis - pathology | Facial Dermatoses - classification | Humans | Middle Aged | Male | Facial Dermatoses - pathology | Epidermis - growth & development | Keratinocytes - pathology | Keratosis, Actinic - classification | Aged, 80 and over | Female | Aged | Retrospective Studies | Keratosis, Actinic - pathology | Medicine, Experimental | Medical research | Analysis | Keratosis
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 1997, Volume 36, Issue 4, pp. 650 - 653
Actinic keratoses are cutaneous neoplasms displaying chromosomal abnormalities that occur primarily on sun-exposed skin surfaces. These premalignant lesions...
K GA DERMATOLOGY & VENEREAL DISEASES | DERMATOLOGY & VENEREAL DISEASES | SKIN-CANCER | SOLAR KERATOSES | P53 | Cocarcinogenesis | Neoplasms, Radiation-Induced - therapy | Precancerous Conditions - etiology | Carcinoma, Squamous Cell - etiology | Precancerous Conditions - therapy | Skin Neoplasms - therapy | Humans | Neoplasms, Radiation-Induced - etiology | Carcinoma, Squamous Cell - therapy | Skin Neoplasms - etiology | Squamous cell carcinoma | Tumor proteins | Radiation | Keratosis
K GA DERMATOLOGY & VENEREAL DISEASES | DERMATOLOGY & VENEREAL DISEASES | SKIN-CANCER | SOLAR KERATOSES | P53 | Cocarcinogenesis | Neoplasms, Radiation-Induced - therapy | Precancerous Conditions - etiology | Carcinoma, Squamous Cell - etiology | Precancerous Conditions - therapy | Skin Neoplasms - therapy | Humans | Neoplasms, Radiation-Induced - etiology | Carcinoma, Squamous Cell - therapy | Skin Neoplasms - etiology | Squamous cell carcinoma | Tumor proteins | Radiation | Keratosis
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2012, Volume 68, Issue 1, pp. S39 - S48
Actinic keratosis (AK) is a common ultraviolet light–induced skin lesion found on sun-exposed skin areas generally in older, fair-skinned people. It is part of...
Dermatology | local skin response | ingenol mebutate | field cancerization | field therapy | actinic keratosis | PROTEIN-KINASE-C | RANDOMIZED CONTROLLED-TRIAL | TRANSPLANT RECIPIENTS | SOLAR KERATOSES | DERMATOLOGY | P53 MUTATIONS | NONMELANOMA SKIN-CANCER | REGULAR SUNSCREEN USE | IMMUNOCOMPETENT PATIENTS | SQUAMOUS-CELL CARCINOMAS | BASAL-CELL | Skin Neoplasms - pathology | Diterpenes - therapeutic use | Keratinocytes - pathology | Keratosis, Actinic - drug therapy | Humans | Female | Male | Aged | Clinical Trials as Topic | Skin - pathology | Medical research | Squamous cell carcinoma | Medicine, Experimental | Skin | Health aspects | Keratosis | Skin cancer | Index Medicus
Dermatology | local skin response | ingenol mebutate | field cancerization | field therapy | actinic keratosis | PROTEIN-KINASE-C | RANDOMIZED CONTROLLED-TRIAL | TRANSPLANT RECIPIENTS | SOLAR KERATOSES | DERMATOLOGY | P53 MUTATIONS | NONMELANOMA SKIN-CANCER | REGULAR SUNSCREEN USE | IMMUNOCOMPETENT PATIENTS | SQUAMOUS-CELL CARCINOMAS | BASAL-CELL | Skin Neoplasms - pathology | Diterpenes - therapeutic use | Keratinocytes - pathology | Keratosis, Actinic - drug therapy | Humans | Female | Male | Aged | Clinical Trials as Topic | Skin - pathology | Medical research | Squamous cell carcinoma | Medicine, Experimental | Skin | Health aspects | Keratosis | Skin cancer | Index Medicus
Journal Article
American Family Physician, ISSN 0002-838X, 09/2007, Volume 76, Issue 5, pp. 667 - 672
Actinic keratoses are rough, scaly lesions that commonly occur on sun-exposed areas of the skin. The prevalence of the condition increases with age. Actinic...
MEDICINE, GENERAL & INTERNAL | IMIQUIMOD 5-PERCENT CREAM | PHOTODYNAMIC THERAPY | CLINICAL-TRIAL | VEHICLE-CONTROLLED TRIALS | PARALLEL-GROUP | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | FLUOROURACIL | SKIN-CANCER | SOLAR KERATOSES | Prevalence | Cryosurgery | Humans | Aminoquinolines - administration & dosage | Chemexfoliation | Antineoplastic Agents - administration & dosage | Keratosis - diagnosis | Photochemotherapy | Curettage | Fluorouracil - administration & dosage | Skin Neoplasms - prevention & control | Keratosis - therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Diclofenac - administration & dosage | Administration, Topical | Keratosis - epidemiology | Actinic keratosis | Care and treatment | Dermatology | Surgery | Formulae, receipts, prescriptions | Dermatologic agents | Dosage and administration | Skin | Methods
MEDICINE, GENERAL & INTERNAL | IMIQUIMOD 5-PERCENT CREAM | PHOTODYNAMIC THERAPY | CLINICAL-TRIAL | VEHICLE-CONTROLLED TRIALS | PARALLEL-GROUP | SQUAMOUS-CELL CARCINOMA | DOUBLE-BLIND | FLUOROURACIL | SKIN-CANCER | SOLAR KERATOSES | Prevalence | Cryosurgery | Humans | Aminoquinolines - administration & dosage | Chemexfoliation | Antineoplastic Agents - administration & dosage | Keratosis - diagnosis | Photochemotherapy | Curettage | Fluorouracil - administration & dosage | Skin Neoplasms - prevention & control | Keratosis - therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Diclofenac - administration & dosage | Administration, Topical | Keratosis - epidemiology | Actinic keratosis | Care and treatment | Dermatology | Surgery | Formulae, receipts, prescriptions | Dermatologic agents | Dosage and administration | Skin | Methods
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 11/2014, Volume 28, Issue 11, pp. 1529 - 1539
Background Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is effective for treating multiple actinic keratoses (AKs). Ablative fractional laser...
MULTICENTER | TOPICAL METHYL-AMINOLEVULINATE | ACID | FLUORESCENCE | 5-AMINOLEVULINATE | YTTRIUM-ALUMINUM-GARNET | DOUBLE-BLIND | SKIN | CELL CARCINOMA | SOLAR KERATOSES | DERMATOLOGY | Recurrence | Prospective Studies | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Patient Satisfaction | Time Factors | Female | Face | Republic of Korea | Severity of Illness Index | Lasers, Solid-State - therapeutic use | Photochemotherapy - adverse effects | Keratosis, Actinic - ethnology | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Lasers, Solid-State - adverse effects | Aminolevulinic Acid - adverse effects | Asian Continental Ancestry Group | Keratosis, Actinic - drug therapy | Aminolevulinic Acid - analogs & derivatives | Aged | Keratosis, Actinic - surgery | Rare earth metals | Care and treatment | Comparative analysis | Light-emitting diodes | Photochemotherapy | Lasers in medicine | Keratosis | Cancer
MULTICENTER | TOPICAL METHYL-AMINOLEVULINATE | ACID | FLUORESCENCE | 5-AMINOLEVULINATE | YTTRIUM-ALUMINUM-GARNET | DOUBLE-BLIND | SKIN | CELL CARCINOMA | SOLAR KERATOSES | DERMATOLOGY | Recurrence | Prospective Studies | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Patient Satisfaction | Time Factors | Female | Face | Republic of Korea | Severity of Illness Index | Lasers, Solid-State - therapeutic use | Photochemotherapy - adverse effects | Keratosis, Actinic - ethnology | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Lasers, Solid-State - adverse effects | Aminolevulinic Acid - adverse effects | Asian Continental Ancestry Group | Keratosis, Actinic - drug therapy | Aminolevulinic Acid - analogs & derivatives | Aged | Keratosis, Actinic - surgery | Rare earth metals | Care and treatment | Comparative analysis | Light-emitting diodes | Photochemotherapy | Lasers in medicine | Keratosis | Cancer
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2000, Volume 42, Issue 1, pp. S4 - S7
Objective: The purpose of this article was to review the frequency; distribution, and determinants of actinic keratoses (AKs) and squamous cell carcinoma...
MARYLAND WATERMEN | AUSTRALIA | LIP | NONMELANOMA SKIN-CANCER | PUVA | RISK | ASSOCIATION | EXPOSURE | SOLAR KERATOSES | DERMATOLOGY | Photosensitivity Disorders - epidemiology | Carcinoma, Squamous Cell - epidemiology | Skin Neoplasms - epidemiology | Humans | Keratosis - epidemiology | Epidemiology | Squamous cell carcinoma
MARYLAND WATERMEN | AUSTRALIA | LIP | NONMELANOMA SKIN-CANCER | PUVA | RISK | ASSOCIATION | EXPOSURE | SOLAR KERATOSES | DERMATOLOGY | Photosensitivity Disorders - epidemiology | Carcinoma, Squamous Cell - epidemiology | Skin Neoplasms - epidemiology | Humans | Keratosis - epidemiology | Epidemiology | Squamous cell carcinoma
Journal Article
Dermatology, ISSN 1018-8665, 01/2010, Volume 220, Issue 1, pp. 15 - 24
Background: Actinic keratoses (AK) represent cutaneous carcinoma in situ and have previously been evaluated by ref